In the present study, we found that CHFR overexpression decreased the level of Aurora A, and elevated the sensitivity to paclitaxel; and conversely, CHFR reduction increased the level of Aurora A and reduced the sensitivity to paclitaxel in ovarian cancer cells. This evidence concerns the gene CHFR and ovarian cancer.